The verdict is in: new vancomycin dosing guidelines are redefining how hospitals manage patient safety and antibiotic stewardship. While traditional trough-based methods remain common, research shows that AUC-guided, Bayesian-informed dosing delivers better outcomes, lower nephrotoxicity, and higher precision.
In this white paper, InsightRX clinical experts review the evidence behind the new 2020 guidelines, explain why rapid adoption is critical, and show how model-informed precision dosing (MIPD) software can simplify implementation across pharmacy teams.
Learn how your organization can:
- Help clinicians make better decisions, which can lead to reduced vancomycin-related acute kidney injuries (AKIs)
- Improve dosing accuracy with Bayesian forecasting
- Build a continuously learning dosing program that adapts over time
Click below to download the full white paper and discover how InsightRX helps hospitals deliver safer, smarter, and more efficient patient care.
